MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis

De Vito, F; Musella, A; Fresegna, D; Rizzo, FR; Gentile, A; Bassi, MS; Gilio, L; Buttari, F; Procaccini, C; Colamatteo, A; Bullitta, S; Guadalupi, L; Caioli, S; Vanni, V; Balletta, S; Sanna, K; Bruno, A; Dolcetti, E; Furlan, R; Finardi, A; Licursi, V; Drulovic, J; Pekmezovic, T; Fusco, C; Bruzzaniti, S; Hornstein, E; Uccelli, A; Salvetti, M; Matarese, G; Centonze, D; Mandolesi, G

Centonze, D (通讯作者)，Tor Vergata Univ, Dept Syst Med, Rome, Italy.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2022; 48 (2):

Abstract

Aim We recently proposed miR-142-3p as a molecular player in inflammatory synaptopathy, a new pathogenic hallmark of multiple sclerosis (MS) and of it......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索